Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders

16 Mar 2020

Abstract excerpt

Rheumatoid Arthritis (RA), Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are the systemic autoimmune diseases (SADs) most associated with an increased risk of developing cardiovascular (CV) events. Cardiovascular disease (CVD) in SADs results from a complex interaction between traditional CV-risk factors, immune deregulation and disease activity. Oxidative stress, dyslipidemia,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation
Share to Systemic Lupus Erythematosus Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32188016
DOI: 10.3390/ijms21062012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune DisordersPMID 32188016Read ↗

Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory FunctionsSemantic proximity Read ↗

Cardiovascular Consequences of Autoimmune Rheumatic Diseases.Semantic proximity Read ↗

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)Semantic proximity Read ↗

Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping reviewSemantic proximity Read ↗

‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’Semantic proximity Read ↗

Cardiovascular Involvement in Autoimmune DiseasesSemantic proximity Read ↗

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics ApproachesSemantic proximity Read ↗

Systemic lupus erythematosus-accelerated atherosclerosis: mechanistic insights and clinical implications.Semantic proximity Read ↗

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Semantic proximity Read ↗

A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting AtherosclerosisSemantic proximity Read ↗

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic AnalysesSemantic proximity Read ↗

The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.